Global Emerging Infectious Disease Supply, Demand and Key Producers, 2023-2029
The global Emerging Infectious Disease market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.
This report studies the global Emerging Infectious Disease demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Emerging Infectious Disease, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Emerging Infectious Disease that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Emerging Infectious Disease total market, 2018-2029, (USD Million)
Global Emerging Infectious Disease total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Emerging Infectious Disease total market, key domestic companies and share, (USD Million)
Global Emerging Infectious Disease revenue by player and market share 2018-2023, (USD Million)
Global Emerging Infectious Disease total market by Type, CAGR, 2018-2029, (USD Million)
Global Emerging Infectious Disease total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Emerging Infectious Disease market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex and Gen-Probe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Emerging Infectious Disease market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Emerging Infectious Disease Market, By Region:
1. How big is the global Emerging Infectious Disease market?
2. What is the demand of the global Emerging Infectious Disease market?
3. What is the year over year growth of the global Emerging Infectious Disease market?
4. What is the total value of the global Emerging Infectious Disease market?
5. Who are the major players in the global Emerging Infectious Disease market?
6. What are the growth factors driving the market demand?
Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.
This report studies the global Emerging Infectious Disease demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Emerging Infectious Disease, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Emerging Infectious Disease that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Emerging Infectious Disease total market, 2018-2029, (USD Million)
Global Emerging Infectious Disease total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Emerging Infectious Disease total market, key domestic companies and share, (USD Million)
Global Emerging Infectious Disease revenue by player and market share 2018-2023, (USD Million)
Global Emerging Infectious Disease total market by Type, CAGR, 2018-2029, (USD Million)
Global Emerging Infectious Disease total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Emerging Infectious Disease market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Abbott, BioMerieux, Danaher, Orasure, Qiagen, Quidel, Sysmex and Gen-Probe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Emerging Infectious Disease market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Emerging Infectious Disease Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- AIDS
- Ebola
- SARS
- Avian Flu
- Chikungunya
- Zika
- Others
- Clinical Laboratories
- Diagnostic Centers
- Others
- BD
- Abbott
- BioMerieux
- Danaher
- Orasure
- Qiagen
- Quidel
- Sysmex
- Gen-Probe
- Cepheid
- Hologic
1. How big is the global Emerging Infectious Disease market?
2. What is the demand of the global Emerging Infectious Disease market?
3. What is the year over year growth of the global Emerging Infectious Disease market?
4. What is the total value of the global Emerging Infectious Disease market?
5. Who are the major players in the global Emerging Infectious Disease market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Emerging Infectious Disease Introduction
1.2 World Emerging Infectious Disease Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Emerging Infectious Disease Total Market by Region (by Headquarter Location)
1.3.1 World Emerging Infectious Disease Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Emerging Infectious Disease Market Size (2018-2029)
1.3.3 China Emerging Infectious Disease Market Size (2018-2029)
1.3.4 Europe Emerging Infectious Disease Market Size (2018-2029)
1.3.5 Japan Emerging Infectious Disease Market Size (2018-2029)
1.3.6 South Korea Emerging Infectious Disease Market Size (2018-2029)
1.3.7 ASEAN Emerging Infectious Disease Market Size (2018-2029)
1.3.8 India Emerging Infectious Disease Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Emerging Infectious Disease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Emerging Infectious Disease Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Emerging Infectious Disease Consumption Value (2018-2029)
2.2 World Emerging Infectious Disease Consumption Value by Region
2.2.1 World Emerging Infectious Disease Consumption Value by Region (2018-2023)
2.2.2 World Emerging Infectious Disease Consumption Value Forecast by Region (2024-2029)
2.3 United States Emerging Infectious Disease Consumption Value (2018-2029)
2.4 China Emerging Infectious Disease Consumption Value (2018-2029)
2.5 Europe Emerging Infectious Disease Consumption Value (2018-2029)
2.6 Japan Emerging Infectious Disease Consumption Value (2018-2029)
2.7 South Korea Emerging Infectious Disease Consumption Value (2018-2029)
2.8 ASEAN Emerging Infectious Disease Consumption Value (2018-2029)
2.9 India Emerging Infectious Disease Consumption Value (2018-2029)
3 WORLD EMERGING INFECTIOUS DISEASE COMPANIES COMPETITIVE ANALYSIS
3.1 World Emerging Infectious Disease Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Emerging Infectious Disease Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Emerging Infectious Disease in 2022
3.2.3 Global Concentration Ratios (CR8) for Emerging Infectious Disease in 2022
3.3 Emerging Infectious Disease Company Evaluation Quadrant
3.4 Emerging Infectious Disease Market: Overall Company Footprint Analysis
3.4.1 Emerging Infectious Disease Market: Region Footprint
3.4.2 Emerging Infectious Disease Market: Company Product Type Footprint
3.4.3 Emerging Infectious Disease Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Emerging Infectious Disease Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Emerging Infectious Disease Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Emerging Infectious Disease Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Emerging Infectious Disease Consumption Value Comparison
4.2.1 United States VS China: Emerging Infectious Disease Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Emerging Infectious Disease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Emerging Infectious Disease Companies and Market Share, 2018-2023
4.3.1 United States Based Emerging Infectious Disease Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Emerging Infectious Disease Revenue, (2018-2023)
4.4 China Based Companies Emerging Infectious Disease Revenue and Market Share, 2018-2023
4.4.1 China Based Emerging Infectious Disease Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Emerging Infectious Disease Revenue, (2018-2023)
4.5 Rest of World Based Emerging Infectious Disease Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Emerging Infectious Disease Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Emerging Infectious Disease Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Emerging Infectious Disease Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 AIDS
5.2.2 Ebola
5.2.3 SARS
5.2.4 Avian Flu
5.2.5 Chikungunya
5.2.6 Zika
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Emerging Infectious Disease Market Size by Type (2018-2023)
5.3.2 World Emerging Infectious Disease Market Size by Type (2024-2029)
5.3.3 World Emerging Infectious Disease Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Emerging Infectious Disease Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Laboratories
6.2.2 Diagnostic Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Emerging Infectious Disease Market Size by Application (2018-2023)
6.3.2 World Emerging Infectious Disease Market Size by Application (2024-2029)
6.3.3 World Emerging Infectious Disease Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Emerging Infectious Disease Product and Services
7.1.4 BD Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Emerging Infectious Disease Product and Services
7.2.4 Abbott Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 BioMerieux
7.3.1 BioMerieux Details
7.3.2 BioMerieux Major Business
7.3.3 BioMerieux Emerging Infectious Disease Product and Services
7.3.4 BioMerieux Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BioMerieux Recent Developments/Updates
7.3.6 BioMerieux Competitive Strengths & Weaknesses
7.4 Danaher
7.4.1 Danaher Details
7.4.2 Danaher Major Business
7.4.3 Danaher Emerging Infectious Disease Product and Services
7.4.4 Danaher Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Danaher Recent Developments/Updates
7.4.6 Danaher Competitive Strengths & Weaknesses
7.5 Orasure
7.5.1 Orasure Details
7.5.2 Orasure Major Business
7.5.3 Orasure Emerging Infectious Disease Product and Services
7.5.4 Orasure Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Orasure Recent Developments/Updates
7.5.6 Orasure Competitive Strengths & Weaknesses
7.6 Qiagen
7.6.1 Qiagen Details
7.6.2 Qiagen Major Business
7.6.3 Qiagen Emerging Infectious Disease Product and Services
7.6.4 Qiagen Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Qiagen Recent Developments/Updates
7.6.6 Qiagen Competitive Strengths & Weaknesses
7.7 Quidel
7.7.1 Quidel Details
7.7.2 Quidel Major Business
7.7.3 Quidel Emerging Infectious Disease Product and Services
7.7.4 Quidel Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Quidel Recent Developments/Updates
7.7.6 Quidel Competitive Strengths & Weaknesses
7.8 Sysmex
7.8.1 Sysmex Details
7.8.2 Sysmex Major Business
7.8.3 Sysmex Emerging Infectious Disease Product and Services
7.8.4 Sysmex Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sysmex Recent Developments/Updates
7.8.6 Sysmex Competitive Strengths & Weaknesses
7.9 Gen-Probe
7.9.1 Gen-Probe Details
7.9.2 Gen-Probe Major Business
7.9.3 Gen-Probe Emerging Infectious Disease Product and Services
7.9.4 Gen-Probe Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Gen-Probe Recent Developments/Updates
7.9.6 Gen-Probe Competitive Strengths & Weaknesses
7.10 Cepheid
7.10.1 Cepheid Details
7.10.2 Cepheid Major Business
7.10.3 Cepheid Emerging Infectious Disease Product and Services
7.10.4 Cepheid Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cepheid Recent Developments/Updates
7.10.6 Cepheid Competitive Strengths & Weaknesses
7.11 Hologic
7.11.1 Hologic Details
7.11.2 Hologic Major Business
7.11.3 Hologic Emerging Infectious Disease Product and Services
7.11.4 Hologic Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hologic Recent Developments/Updates
7.11.6 Hologic Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Emerging Infectious Disease Industry Chain
8.2 Emerging Infectious Disease Upstream Analysis
8.3 Emerging Infectious Disease Midstream Analysis
8.4 Emerging Infectious Disease Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Emerging Infectious Disease Introduction
1.2 World Emerging Infectious Disease Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Emerging Infectious Disease Total Market by Region (by Headquarter Location)
1.3.1 World Emerging Infectious Disease Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Emerging Infectious Disease Market Size (2018-2029)
1.3.3 China Emerging Infectious Disease Market Size (2018-2029)
1.3.4 Europe Emerging Infectious Disease Market Size (2018-2029)
1.3.5 Japan Emerging Infectious Disease Market Size (2018-2029)
1.3.6 South Korea Emerging Infectious Disease Market Size (2018-2029)
1.3.7 ASEAN Emerging Infectious Disease Market Size (2018-2029)
1.3.8 India Emerging Infectious Disease Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Emerging Infectious Disease Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Emerging Infectious Disease Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Emerging Infectious Disease Consumption Value (2018-2029)
2.2 World Emerging Infectious Disease Consumption Value by Region
2.2.1 World Emerging Infectious Disease Consumption Value by Region (2018-2023)
2.2.2 World Emerging Infectious Disease Consumption Value Forecast by Region (2024-2029)
2.3 United States Emerging Infectious Disease Consumption Value (2018-2029)
2.4 China Emerging Infectious Disease Consumption Value (2018-2029)
2.5 Europe Emerging Infectious Disease Consumption Value (2018-2029)
2.6 Japan Emerging Infectious Disease Consumption Value (2018-2029)
2.7 South Korea Emerging Infectious Disease Consumption Value (2018-2029)
2.8 ASEAN Emerging Infectious Disease Consumption Value (2018-2029)
2.9 India Emerging Infectious Disease Consumption Value (2018-2029)
3 WORLD EMERGING INFECTIOUS DISEASE COMPANIES COMPETITIVE ANALYSIS
3.1 World Emerging Infectious Disease Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Emerging Infectious Disease Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Emerging Infectious Disease in 2022
3.2.3 Global Concentration Ratios (CR8) for Emerging Infectious Disease in 2022
3.3 Emerging Infectious Disease Company Evaluation Quadrant
3.4 Emerging Infectious Disease Market: Overall Company Footprint Analysis
3.4.1 Emerging Infectious Disease Market: Region Footprint
3.4.2 Emerging Infectious Disease Market: Company Product Type Footprint
3.4.3 Emerging Infectious Disease Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Emerging Infectious Disease Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Emerging Infectious Disease Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Emerging Infectious Disease Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Emerging Infectious Disease Consumption Value Comparison
4.2.1 United States VS China: Emerging Infectious Disease Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Emerging Infectious Disease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Emerging Infectious Disease Companies and Market Share, 2018-2023
4.3.1 United States Based Emerging Infectious Disease Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Emerging Infectious Disease Revenue, (2018-2023)
4.4 China Based Companies Emerging Infectious Disease Revenue and Market Share, 2018-2023
4.4.1 China Based Emerging Infectious Disease Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Emerging Infectious Disease Revenue, (2018-2023)
4.5 Rest of World Based Emerging Infectious Disease Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Emerging Infectious Disease Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Emerging Infectious Disease Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Emerging Infectious Disease Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 AIDS
5.2.2 Ebola
5.2.3 SARS
5.2.4 Avian Flu
5.2.5 Chikungunya
5.2.6 Zika
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Emerging Infectious Disease Market Size by Type (2018-2023)
5.3.2 World Emerging Infectious Disease Market Size by Type (2024-2029)
5.3.3 World Emerging Infectious Disease Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Emerging Infectious Disease Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Clinical Laboratories
6.2.2 Diagnostic Centers
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Emerging Infectious Disease Market Size by Application (2018-2023)
6.3.2 World Emerging Infectious Disease Market Size by Application (2024-2029)
6.3.3 World Emerging Infectious Disease Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 BD
7.1.1 BD Details
7.1.2 BD Major Business
7.1.3 BD Emerging Infectious Disease Product and Services
7.1.4 BD Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 BD Recent Developments/Updates
7.1.6 BD Competitive Strengths & Weaknesses
7.2 Abbott
7.2.1 Abbott Details
7.2.2 Abbott Major Business
7.2.3 Abbott Emerging Infectious Disease Product and Services
7.2.4 Abbott Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Abbott Recent Developments/Updates
7.2.6 Abbott Competitive Strengths & Weaknesses
7.3 BioMerieux
7.3.1 BioMerieux Details
7.3.2 BioMerieux Major Business
7.3.3 BioMerieux Emerging Infectious Disease Product and Services
7.3.4 BioMerieux Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 BioMerieux Recent Developments/Updates
7.3.6 BioMerieux Competitive Strengths & Weaknesses
7.4 Danaher
7.4.1 Danaher Details
7.4.2 Danaher Major Business
7.4.3 Danaher Emerging Infectious Disease Product and Services
7.4.4 Danaher Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Danaher Recent Developments/Updates
7.4.6 Danaher Competitive Strengths & Weaknesses
7.5 Orasure
7.5.1 Orasure Details
7.5.2 Orasure Major Business
7.5.3 Orasure Emerging Infectious Disease Product and Services
7.5.4 Orasure Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Orasure Recent Developments/Updates
7.5.6 Orasure Competitive Strengths & Weaknesses
7.6 Qiagen
7.6.1 Qiagen Details
7.6.2 Qiagen Major Business
7.6.3 Qiagen Emerging Infectious Disease Product and Services
7.6.4 Qiagen Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Qiagen Recent Developments/Updates
7.6.6 Qiagen Competitive Strengths & Weaknesses
7.7 Quidel
7.7.1 Quidel Details
7.7.2 Quidel Major Business
7.7.3 Quidel Emerging Infectious Disease Product and Services
7.7.4 Quidel Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Quidel Recent Developments/Updates
7.7.6 Quidel Competitive Strengths & Weaknesses
7.8 Sysmex
7.8.1 Sysmex Details
7.8.2 Sysmex Major Business
7.8.3 Sysmex Emerging Infectious Disease Product and Services
7.8.4 Sysmex Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Sysmex Recent Developments/Updates
7.8.6 Sysmex Competitive Strengths & Weaknesses
7.9 Gen-Probe
7.9.1 Gen-Probe Details
7.9.2 Gen-Probe Major Business
7.9.3 Gen-Probe Emerging Infectious Disease Product and Services
7.9.4 Gen-Probe Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Gen-Probe Recent Developments/Updates
7.9.6 Gen-Probe Competitive Strengths & Weaknesses
7.10 Cepheid
7.10.1 Cepheid Details
7.10.2 Cepheid Major Business
7.10.3 Cepheid Emerging Infectious Disease Product and Services
7.10.4 Cepheid Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cepheid Recent Developments/Updates
7.10.6 Cepheid Competitive Strengths & Weaknesses
7.11 Hologic
7.11.1 Hologic Details
7.11.2 Hologic Major Business
7.11.3 Hologic Emerging Infectious Disease Product and Services
7.11.4 Hologic Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Hologic Recent Developments/Updates
7.11.6 Hologic Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Emerging Infectious Disease Industry Chain
8.2 Emerging Infectious Disease Upstream Analysis
8.3 Emerging Infectious Disease Midstream Analysis
8.4 Emerging Infectious Disease Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Emerging Infectious Disease Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Emerging Infectious Disease Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Emerging Infectious Disease Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Emerging Infectious Disease Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Emerging Infectious Disease Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Emerging Infectious Disease Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Emerging Infectious Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Emerging Infectious Disease Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Emerging Infectious Disease Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Emerging Infectious Disease Players in 2022
Table 12. World Emerging Infectious Disease Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Emerging Infectious Disease Company Evaluation Quadrant
Table 14. Head Office of Key Emerging Infectious Disease Player
Table 15. Emerging Infectious Disease Market: Company Product Type Footprint
Table 16. Emerging Infectious Disease Market: Company Product Application Footprint
Table 17. Emerging Infectious Disease Mergers & Acquisitions Activity
Table 18. United States VS China Emerging Infectious Disease Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Emerging Infectious Disease Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Emerging Infectious Disease Companies, Headquarters (States, Country)
Table 21. United States Based Companies Emerging Infectious Disease Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Emerging Infectious Disease Revenue Market Share (2018-2023)
Table 23. China Based Emerging Infectious Disease Companies, Headquarters (Province, Country)
Table 24. China Based Companies Emerging Infectious Disease Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Emerging Infectious Disease Revenue Market Share (2018-2023)
Table 26. Rest of World Based Emerging Infectious Disease Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Emerging Infectious Disease Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Emerging Infectious Disease Revenue Market Share (2018-2023)
Table 29. World Emerging Infectious Disease Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Emerging Infectious Disease Market Size by Type (2018-2023) & (USD Million)
Table 31. World Emerging Infectious Disease Market Size by Type (2024-2029) & (USD Million)
Table 32. World Emerging Infectious Disease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Emerging Infectious Disease Market Size by Application (2018-2023) & (USD Million)
Table 34. World Emerging Infectious Disease Market Size by Application (2024-2029) & (USD Million)
Table 35. BD Basic Information, Area Served and Competitors
Table 36. BD Major Business
Table 37. BD Emerging Infectious Disease Product and Services
Table 38. BD Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BD Recent Developments/Updates
Table 40. BD Competitive Strengths & Weaknesses
Table 41. Abbott Basic Information, Area Served and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Emerging Infectious Disease Product and Services
Table 44. Abbott Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. BioMerieux Basic Information, Area Served and Competitors
Table 48. BioMerieux Major Business
Table 49. BioMerieux Emerging Infectious Disease Product and Services
Table 50. BioMerieux Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BioMerieux Recent Developments/Updates
Table 52. BioMerieux Competitive Strengths & Weaknesses
Table 53. Danaher Basic Information, Area Served and Competitors
Table 54. Danaher Major Business
Table 55. Danaher Emerging Infectious Disease Product and Services
Table 56. Danaher Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Danaher Recent Developments/Updates
Table 58. Danaher Competitive Strengths & Weaknesses
Table 59. Orasure Basic Information, Area Served and Competitors
Table 60. Orasure Major Business
Table 61. Orasure Emerging Infectious Disease Product and Services
Table 62. Orasure Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Orasure Recent Developments/Updates
Table 64. Orasure Competitive Strengths & Weaknesses
Table 65. Qiagen Basic Information, Area Served and Competitors
Table 66. Qiagen Major Business
Table 67. Qiagen Emerging Infectious Disease Product and Services
Table 68. Qiagen Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Qiagen Recent Developments/Updates
Table 70. Qiagen Competitive Strengths & Weaknesses
Table 71. Quidel Basic Information, Area Served and Competitors
Table 72. Quidel Major Business
Table 73. Quidel Emerging Infectious Disease Product and Services
Table 74. Quidel Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Quidel Recent Developments/Updates
Table 76. Quidel Competitive Strengths & Weaknesses
Table 77. Sysmex Basic Information, Area Served and Competitors
Table 78. Sysmex Major Business
Table 79. Sysmex Emerging Infectious Disease Product and Services
Table 80. Sysmex Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sysmex Recent Developments/Updates
Table 82. Sysmex Competitive Strengths & Weaknesses
Table 83. Gen-Probe Basic Information, Area Served and Competitors
Table 84. Gen-Probe Major Business
Table 85. Gen-Probe Emerging Infectious Disease Product and Services
Table 86. Gen-Probe Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Gen-Probe Recent Developments/Updates
Table 88. Gen-Probe Competitive Strengths & Weaknesses
Table 89. Cepheid Basic Information, Area Served and Competitors
Table 90. Cepheid Major Business
Table 91. Cepheid Emerging Infectious Disease Product and Services
Table 92. Cepheid Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cepheid Recent Developments/Updates
Table 94. Hologic Basic Information, Area Served and Competitors
Table 95. Hologic Major Business
Table 96. Hologic Emerging Infectious Disease Product and Services
Table 97. Hologic Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Emerging Infectious Disease Upstream (Raw Materials)
Table 99. Emerging Infectious Disease Typical Customers
Table 1. World Emerging Infectious Disease Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Emerging Infectious Disease Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Emerging Infectious Disease Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Emerging Infectious Disease Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Emerging Infectious Disease Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Emerging Infectious Disease Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Emerging Infectious Disease Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Emerging Infectious Disease Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Emerging Infectious Disease Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Emerging Infectious Disease Players in 2022
Table 12. World Emerging Infectious Disease Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Emerging Infectious Disease Company Evaluation Quadrant
Table 14. Head Office of Key Emerging Infectious Disease Player
Table 15. Emerging Infectious Disease Market: Company Product Type Footprint
Table 16. Emerging Infectious Disease Market: Company Product Application Footprint
Table 17. Emerging Infectious Disease Mergers & Acquisitions Activity
Table 18. United States VS China Emerging Infectious Disease Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Emerging Infectious Disease Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Emerging Infectious Disease Companies, Headquarters (States, Country)
Table 21. United States Based Companies Emerging Infectious Disease Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Emerging Infectious Disease Revenue Market Share (2018-2023)
Table 23. China Based Emerging Infectious Disease Companies, Headquarters (Province, Country)
Table 24. China Based Companies Emerging Infectious Disease Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Emerging Infectious Disease Revenue Market Share (2018-2023)
Table 26. Rest of World Based Emerging Infectious Disease Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Emerging Infectious Disease Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Emerging Infectious Disease Revenue Market Share (2018-2023)
Table 29. World Emerging Infectious Disease Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Emerging Infectious Disease Market Size by Type (2018-2023) & (USD Million)
Table 31. World Emerging Infectious Disease Market Size by Type (2024-2029) & (USD Million)
Table 32. World Emerging Infectious Disease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Emerging Infectious Disease Market Size by Application (2018-2023) & (USD Million)
Table 34. World Emerging Infectious Disease Market Size by Application (2024-2029) & (USD Million)
Table 35. BD Basic Information, Area Served and Competitors
Table 36. BD Major Business
Table 37. BD Emerging Infectious Disease Product and Services
Table 38. BD Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. BD Recent Developments/Updates
Table 40. BD Competitive Strengths & Weaknesses
Table 41. Abbott Basic Information, Area Served and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Emerging Infectious Disease Product and Services
Table 44. Abbott Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. BioMerieux Basic Information, Area Served and Competitors
Table 48. BioMerieux Major Business
Table 49. BioMerieux Emerging Infectious Disease Product and Services
Table 50. BioMerieux Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. BioMerieux Recent Developments/Updates
Table 52. BioMerieux Competitive Strengths & Weaknesses
Table 53. Danaher Basic Information, Area Served and Competitors
Table 54. Danaher Major Business
Table 55. Danaher Emerging Infectious Disease Product and Services
Table 56. Danaher Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Danaher Recent Developments/Updates
Table 58. Danaher Competitive Strengths & Weaknesses
Table 59. Orasure Basic Information, Area Served and Competitors
Table 60. Orasure Major Business
Table 61. Orasure Emerging Infectious Disease Product and Services
Table 62. Orasure Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Orasure Recent Developments/Updates
Table 64. Orasure Competitive Strengths & Weaknesses
Table 65. Qiagen Basic Information, Area Served and Competitors
Table 66. Qiagen Major Business
Table 67. Qiagen Emerging Infectious Disease Product and Services
Table 68. Qiagen Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Qiagen Recent Developments/Updates
Table 70. Qiagen Competitive Strengths & Weaknesses
Table 71. Quidel Basic Information, Area Served and Competitors
Table 72. Quidel Major Business
Table 73. Quidel Emerging Infectious Disease Product and Services
Table 74. Quidel Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Quidel Recent Developments/Updates
Table 76. Quidel Competitive Strengths & Weaknesses
Table 77. Sysmex Basic Information, Area Served and Competitors
Table 78. Sysmex Major Business
Table 79. Sysmex Emerging Infectious Disease Product and Services
Table 80. Sysmex Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Sysmex Recent Developments/Updates
Table 82. Sysmex Competitive Strengths & Weaknesses
Table 83. Gen-Probe Basic Information, Area Served and Competitors
Table 84. Gen-Probe Major Business
Table 85. Gen-Probe Emerging Infectious Disease Product and Services
Table 86. Gen-Probe Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Gen-Probe Recent Developments/Updates
Table 88. Gen-Probe Competitive Strengths & Weaknesses
Table 89. Cepheid Basic Information, Area Served and Competitors
Table 90. Cepheid Major Business
Table 91. Cepheid Emerging Infectious Disease Product and Services
Table 92. Cepheid Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cepheid Recent Developments/Updates
Table 94. Hologic Basic Information, Area Served and Competitors
Table 95. Hologic Major Business
Table 96. Hologic Emerging Infectious Disease Product and Services
Table 97. Hologic Emerging Infectious Disease Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Emerging Infectious Disease Upstream (Raw Materials)
Table 99. Emerging Infectious Disease Typical Customers
LIST OF FIGURES
Figure 1. Emerging Infectious Disease Picture
Figure 2. World Emerging Infectious Disease Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Emerging Infectious Disease Total Market Size (2018-2029) & (USD Million)
Figure 4. World Emerging Infectious Disease Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Emerging Infectious Disease Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 13. Emerging Infectious Disease Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 16. World Emerging Infectious Disease Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 18. China Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 23. India Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Emerging Infectious Disease by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Emerging Infectious Disease Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Emerging Infectious Disease Markets in 2022
Figure 27. United States VS China: Emerging Infectious Disease Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Emerging Infectious Disease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Emerging Infectious Disease Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Emerging Infectious Disease Market Size Market Share by Type in 2022
Figure 31. AIDS
Figure 32. Ebola
Figure 33. SARS
Figure 34. Avian Flu
Figure 35. Chikungunya
Figure 36. Zika
Figure 37. Others
Figure 38. World Emerging Infectious Disease Market Size Market Share by Type (2018-2029)
Figure 39. World Emerging Infectious Disease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Emerging Infectious Disease Market Size Market Share by Application in 2022
Figure 41. Clinical Laboratories
Figure 42. Diagnostic Centers
Figure 43. Others
Figure 44. Emerging Infectious Disease Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
Figure 1. Emerging Infectious Disease Picture
Figure 2. World Emerging Infectious Disease Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Emerging Infectious Disease Total Market Size (2018-2029) & (USD Million)
Figure 4. World Emerging Infectious Disease Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Emerging Infectious Disease Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Emerging Infectious Disease Revenue (2018-2029) & (USD Million)
Figure 13. Emerging Infectious Disease Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 16. World Emerging Infectious Disease Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 18. China Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 23. India Emerging Infectious Disease Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Emerging Infectious Disease by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Emerging Infectious Disease Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Emerging Infectious Disease Markets in 2022
Figure 27. United States VS China: Emerging Infectious Disease Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Emerging Infectious Disease Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Emerging Infectious Disease Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Emerging Infectious Disease Market Size Market Share by Type in 2022
Figure 31. AIDS
Figure 32. Ebola
Figure 33. SARS
Figure 34. Avian Flu
Figure 35. Chikungunya
Figure 36. Zika
Figure 37. Others
Figure 38. World Emerging Infectious Disease Market Size Market Share by Type (2018-2029)
Figure 39. World Emerging Infectious Disease Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Emerging Infectious Disease Market Size Market Share by Application in 2022
Figure 41. Clinical Laboratories
Figure 42. Diagnostic Centers
Figure 43. Others
Figure 44. Emerging Infectious Disease Industrial Chain
Figure 45. Methodology
Figure 46. Research Process and Data Source
